| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-09 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-08 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-08 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-08 |